Publications

Targeting pathological ERK1/2 signaling in cancer and beyond

 82
Targeting pathological ERK1/2 signaling in cancer and beyond

Tags:

Previous Article

MAFLD is a ferroptotic disease

Next Article

ERK1/2 signaling targeting in cancer

Related Posts

Activation of lysosomal Ca2+ channels mitigates mitochondrial damage and oxidative stress

Activation of lysosomal Ca2+ channels mitigates mitocho...

 77

Proteostasis, disease and the ageing neuron: Compartmental complexity in non-renewing cells

Proteostasis, disease and the ageing neuron: Compartmen...

 55

Derivation and transcriptional reprogramming of border-forming wound repair astrocytes after spinal cord injury or stroke in mice

Derivation and transcriptional reprogramming of border-...

 54